A quarter of U.S. biotechs are considering shifting away from their current Chinese suppliers, though only 2% have done so. July 5, 2024 Che...Read More
A looming bill has U.S. biotechs wary of partnering with Chinese firms, new report shows
Reviewed by Knowledge World
on
July 05, 2024
Rating: 5